Talat Bessissow

Prognostic Value of Serologic and Histologic Markers on Clinical Relapse in Ulcerative Colitis Patients With Mucosal Healing

Talat Bessissow, Bart Lemmens, Marc Ferrante et al. · The American Journal of Gastroenterology · 2012 · 293 citations

Medicine, Clinical Sciences, Pathology +17

Association Between Ustekinumab Trough Concentrations and Clinical, Biomarker, and Endoscopic Outcomes in Patients With Crohn’s Disease

Robert Battat, Uri Kopylov, Talat Bessissow et al. · Clinical Gastroenterology and Hepatology · 2017 · 234 citations

Medicine, Clinical Sciences, Immunology +16

The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients

Triana Lobatón, Talat Bessissow, Gert De Hertogh et al. · Journal of Crohn s and Colitis · 2015 · 162 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14

Evidence for Neuronal and Structural Changes in Submucous Ganglia of Patients With Functional Dyspepsia

Carla Cirillo, Talat Bessissow, An-Sofie Desmet et al. · The American Journal of Gastroenterology · 2015 · 156 citations

Medicine, Neuroscience, Pathology +13

Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn's disease—The McGill experience

Uri Kopylov, Waqqas Afif, A Cohen et al. · Journal of Crohn s and Colitis · 2014 · 146 citations

Medicine, Immunology, Pharmacotherapy +17